Leerink Partners Maintains Market Perform on PROCEPT BioRobotics, Raises Price Target to $22

Benzinga · 1d ago
Leerink Partners analyst Mike Kratky maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Market Perform and raises the price target from $20 to $22.